Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pentair (PNR) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for Pentair (PNR) over the last 7 years, with Q3 2025 value amounting to $1.5 million.

  • Pentair's Asset Writedowns and Impairment fell 8235.29% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.8 million, marking a year-over-year increase of 41636.36%. This contributed to the annual value of $17.6 million for FY2024, which is 12278.48% up from last year.
  • Latest data reveals that Pentair reported Asset Writedowns and Impairment of $1.5 million as of Q3 2025, which was down 8235.29% from $41.8 million recorded in Q2 2025.
  • Over the past 5 years, Pentair's Asset Writedowns and Impairment peaked at $41.8 million during Q2 2025, and registered a low of $300000.0 during Q2 2023.
  • Over the past 4 years, Pentair's median Asset Writedowns and Impairment value was $4.1 million (recorded in 2023), while the average stood at $9.1 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 9335.94% in 2023, then soared by 55000.0% in 2025.
  • Quarter analysis of 4 years shows Pentair's Asset Writedowns and Impairment stood at $25.6 million in 2022, then tumbled by 93.36% to $1.7 million in 2023, then surged by 388.24% to $8.3 million in 2024, then crashed by 81.93% to $1.5 million in 2025.
  • Its Asset Writedowns and Impairment stands at $1.5 million for Q3 2025, versus $41.8 million for Q2 2025 and $5.2 million for Q1 2025.